The Lyme Disease Association announces that the Food and Drug Administration (FDA) yesterday cleared for marketing four previously cleared tests for the diagnosis of Lyme disease. Called the modified two-tier, […]
This section contains information from the three branches of the federal government: Executive, Legislative, and Judicial. The Lyme Disease Association, Inc. (LDA) has been instrumental for decades in playing a leadership roll in shaping government actions and public policy concerning Lyme and tick-borne diseases.
Congressman Christopher Smith (R-NJ-04) has been pushing for funding and recognition of Lyme and tick-borne diseases over the past 27 years. On July 9, 2019, Mr. Smith testified before the […]
From LDA President Pat Smith’s Blog: The last year has seen a flurry of activity in Washington. Here’s the scoop on the bills, briefings, and bipartisan politics. 2018 HISTORY In the last Congress, May 2018, HR 5900, “National Lyme and Tick-Borne Diseases Control and Accountability Act of 2018’’ was introduced into the US House of Representatives by Congressman Christopher H. Smith (R-NJ)…
The House Lyme Caucus members sent this letter to the House Appropriations Committee for inclusion in the 2020 Labor HHS Appropriations.
May Awareness LDA Guest Blogger Congressman Christopher H. Smith (NJ-04): “A Message from Congressman Chris Smith”…. As the co-chair of the bipartisan House Lyme Disease Caucus, I am deeply grateful and inspired by the Lyme Disease Association, other NGOs, family caregivers, Lyme literate docs, and—above all—the patients who continue to press our government to invest more in research for a cure, the prevention and best treatment options for those with Lyme. […]
Since 2016, the Congressionally Directed Medical Research Programs (CDMRP) Tick-Borne Disease Research Program (TBDRP) has received a $5 million Congressional appropriation each year to allocate to awardees focused on Lyme […]
Lorraine Johnson, JD, MBA, Chief Executive Officer of LymeDisease.org delves into the importance of meaningful patient representation on the Federal HHS Tick-Borne Disease Working Group (TBDWG) in her latest blog. […]